Why the study?
Do maternal exposures such as acute pelvic inflammatory disease, paroxysmal supraventricular tachycardia, phenolphthalein, and folic acid supplementation affect the risk of atrial septal defect secundum in offspring?
Do maternal exposures such as acute pelvic inflammatory disease, paroxysmal supraventricular tachycardia, phenolphthalein, and folic acid supplementation affect the risk of atrial septal defect secundum in offspring?
Answers are grounded in this paper and cite their sources.
Maternal paroxysmal supraventricular tachycardia, acute pelvic inflammatory disease, and phenolphthalein use are associated with an increased risk of atrial septal defect secundum in offspring, whereas high-dose folic acid supplementation in early pregnancy appears protective.
The aim of this study was to assess the risk factors in the origin of lethal or surgically corrected isolated atrial septal defect secundum. The population-based Hungarian Case-Control Surveillance of Congenital Abnormalities (conducted between 1980 and 1996) comprised 472 atrial septal defect secundum cases, 678 matched controls and 38,151 available controls without any defects; in addition, 21,022 malformed controls with other isolated defects. Medically recorded chronic disorders in the prenatal maternity logbook were evaluated, while acute maternal diseases, drug treatments and pregnancy supplements were analyzed on the basis of both prospective medically recorded data and retrospective maternal information. Acute pelvic inflammatory disease, paroxysmal supraventricular tachycardia and phenolphthalein treatment due to severe constipation of mothers were shown to contribute to the development of atrial septal defect secundum of their children. High doses of folic acid in early pregnancy had positively influenced a minor part of isolated atrial septal defect secundum in foetuses. In conclusion, the obvious genetic predisposition for atrial septal defect secundum is connected with maternal paroxysmal supraventricular tachycardia and triggered by acute pelvic inflammatory diseases and phenolphthalein treatment, while the manifestation of atrial septal defect secundum can be reduced by high doses of folic acid supplementation in early pregnancy.
No takes yet. Share an insight, caveat, or question.
Csáky‐Szunyogh et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: